Z-2887-2026 Class II Ongoing

Recalled by Hardy Diagnostics — Santa Maria, CA

FDA device recall Z-2887-2026 was initiated by Hardy Diagnostics on Jun 8, 2026 and is designated Class II. Reason for recall: Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective… The recall status is ongoing. Affected quantity: 43 units.

Recall details

Product Type
Devices
Report Date
Aug 12, 2026
Initiation Date
Jun 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
43 units

Product description

HardyDisk AST Cefiderocol 30¿g (FDC30) REF Z9435 HardyDisk AST Cefiderocol 30¿g (FDC30) for in vitro agar diffusion susceptibility testing is indicated when there is the need to determine the susceptibility of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii complex and Stenotrophomonas maltophilia to Cefiderocol,

Reason for recall

Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy, potentially resulting in delayed appropriate treatment, prolonged infection, or worsening clinical outcome.

Distribution pattern

U.S. Nationwide distribution in the states of AZ, CA, FL, ID, IN, MA, MS, NJ, NV, NY, OH, PA, and TN.

Code information

Catalog Number: Z9435 UD-DI code: Pending Lot Number: 543461

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2887-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2887-2026. Report a data issue: hello@regdatalab.com.